Company profile: Gelpell
1.1 - Company Overview
Company description
- Provider of manufacturing for food supplements and nutrients, offering soft gelatin capsules for oily and semi-solid preparations; Gelpell® beads for slow, even release and improved bioavailability; hard capsules with powders or Gelpell® beads; plant-based pea-starch soft capsules; blister packaging compliant with pharmaceutical standards; and bulk product supply.
Products and services
- Gelpell® Beads: Gelpell engineers small, transparent gelatin beads that encapsulate active substances for slow, even release and improved bioavailability, employing a controlled-release format to deliver actives steadily over time
- Soft Capsules: Gelpell fabricates gelatin-based soft capsules that contain oily and semi-solid nutrient preparations for easier ingestion and faster absorption, enabling convenient swallowing and rapid uptake
- Hard Capsules: Gelpell constructs two-piece hard capsules comprising two halves filled with nutrient powders or Gelpell® Beads, designed for encapsulating various powder blends and accommodating bead-filled formulations
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Gelpell
Pro-Spectus
HQ: United States
Website
- Description: Provider of healthcare advisory services specializing in the pharmaceutical, medical device, and diagnostic healthcare industries, offering a Patient Access Program that enables patient and market access to therapies by optimizing the patient access journey.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pro-Spectus company profile →
Topo Therapeutics
HQ: United States
Website
- Description: Provider of structural biology expertise to accelerate transmembrane protein drug discovery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Topo Therapeutics company profile →
Astoriom
HQ: United Kingdom
Website
- Description: Provider of ICH-compliant sample stability and biorepository storage solutions for pharmaceutical and medical device sectors, offering controlled temperature/humidity from -196°C to +60°C with cGMP compliance, packaging and transport; custom storage design; equipment service and validation; disaster protection and recovery; and inventory intelligence with real-time reporting and audit trails.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Astoriom company profile →
Seidenader
HQ: Germany
Website
- Description: Provider of inspection machines and applications for manufacturers all over the world.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Seidenader company profile →
Nordic Bioscience
HQ: Denmark
Website
- Description: Provider of ECM-focused biomarker technologies and services for precision drug development, including Protein Fingerprint technology to quantify extracellular matrix fragments in blood, laboratory biomarker analysis for clinical trials, the PRO-C3 biomarker for type III collagen formation, and the GRIPonMASH platform for early MASH detection and management with AI-based decision support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Nordic Bioscience company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Gelpell
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Gelpell
2.2 - Growth funds investing in similar companies to Gelpell
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Gelpell
4.2 - Public trading comparable groups for Gelpell
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →